Cargando…

Prognostic value of H(2)FPEF score in COVID-19

STUDY OBJECTIVE: This study sought to assess the predictive value of H(2)FPEF score in patients with COVID-19. DESIGN: Retrospective study. SETTING: Rush University Medical Center. PARTICIPANTS: A total of 1682 patients had an echocardiogram in the year preceding their COVID-19 admission with a pres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Priya, Ruge, Max, Gomez, Joanne Michelle D., du Fay de Lavallaz, Jeanne, Rao, Anupama, Williams, Kim A., Volgman, Annabelle Santos, Costanzo, Maria Rosa R., Suboc, Tisha, Marinescu, Karolina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Inc. 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887956/ https://www.ncbi.nlm.nih.gov/pubmed/35252908 http://dx.doi.org/10.1016/j.ahjo.2022.100111

Ejemplares similares

INITIAL TROPONIN LEVEL AS A COVID-19 ILLNESS PROGNOSTICATOR
por: Ruge, Max, et al.
Publicado: (2021)

HYPERDYNAMIC LEFT VENTRICULAR EJECTION FRACTION IS A POOR PROGNOSTIC SIGN IN COVID-19 INFECTION
por: Ruge, Max, et al.
Publicado: (2021)

PERSONALIZING THE OPTIMAL CARDIAC TROPONIN THRESHOLD FOR COVID-19 PROGNOSTICATION BASED ON PRE-EXISTING COMORBIDITIES
por: Ruge, Max, et al.
Publicado: (2022)

Hyperdynamic left ventricular ejection fraction is associated with higher mortality in COVID-19 patients
por: Rahman, Annas, et al.
Publicado: (2022)

ASSOCIATION BETWEEN IN-HOSPITAL MORTALITY AND ACE/ARB INHIBITOR USAGE
por: Ruge, Max, et al.
Publicado: (2022)

The prognostic value of cardiac troponin for 60 day mortality and major adverse events in COVID-19 patients
por: Ruge, Max, et al.
Publicado: (2021)

Impact of pre-existing heart failure on 60-day outcomes in patients hospitalized with COVID-19
por: Ruge, Max, et al.
Publicado: (2021)

Cardiovascular findings on chest computed tomography associated with COVID-19 adverse clinical outcomes()
por: Planek, Maria Isabel Camara, et al.
Publicado: (2021)

Clinical outcomes of COVID-19 infection in patients with pre-existing cardiovascular disease
por: Kerolos, Mina Medhat, et al.
Publicado: (2022)

PREVALENCE OF PRE-EXISTING ATRIAL FIBRILLATION AND ASSOCIATION WITH IN-HOSPITAL MORTALITY IN PATIENTS WITH COVID-19
por: Sanders, David, et al.
Publicado: (2022)

CHARACTERICS OF HISPANIC, NON HISPANIC WHITE AND NON-HISPANIC BLACK PATIENTS SCREENED AND HOSPITALIZED FOR COVID-19 IN CHICAGO, USA
por: Fugar, Setri, et al.
Publicado: (2021)

CLINICAL PREDICTORS OF COAGULOPATHY EVENTS IN HOSPITALIZED PATIENTS WITH COVID-19 DISEASE
por: Derbas, Laith, et al.
Publicado: (2021)

CLINICAL CHARACTERISTICS OF NEUROLOGICAL DISEASE AND COVID-19
por: Thakkar, Kajal, et al.
Publicado: (2022)

Echocardiographic predictors of mortality and morbidity in COVID-19 disease using focused cardiovascular ultrasound
por: Gomez, Joanne Michelle D., et al.
Publicado: (2022)

COVID-19-associated takotsubo cardiomyopathy
por: Gomez, Joanne Michelle Dumlao, et al.
Publicado: (2020)

BODY MASS INDEX, INFLAMMATION AND SEVERITY IN HOSPITALIZED COVID-19 PATIENTS: RESULTS FROM A CHICAGO AND MADRID RETROSPECTIVE COHORT STUDY
por: Park, Aaron, et al.
Publicado: (2023)

ECHOCARDIOGRAPHIC AND BIOMARKER PREDICTORS FOR IN-HOSPITAL MORTALITY IN COVID-19 DISEASE
por: Gomez, Joanne Michelle D., et al.
Publicado: (2021)

Editorial commentary: COVID-19 as a cardiovascular disease risk factor
por: Oktay, Ahmet Afşin, et al.
Publicado: (2022)

IDF21-0311 Pre-Admission, Diabetic Glycemic Control on 60-Day Mortality and Major Adverse Cardiovascular Events from COVID-19
por: Ruge, M., et al.
Publicado: (2022)

Tropical Endomyocardial Fibrosis
por: Sutter, Joanne S., et al.
Publicado: (2020)

Association between diastolic stress test and H2FPEF score
por: Rendón-Giraldo, Jairo A., et al.
Publicado: (2022)

Endocarditis Complicated by Severe Aortic Insufficiency in a Patient with COVID-19: Diagnostic and Management Implications
por: Sanders, David J., et al.
Publicado: (2020)

Predictive value of H(2)FPEF score in patients with heart failure with preserved ejection fraction
por: Sun, Yuxi, et al.
Publicado: (2021)

H(2)FPEF score predicts atherosclerosis presence in patients with systemic connective tissue disease
por: Vasilev, Vladimir, et al.
Publicado: (2021)

Prognostic value of the H(2)FPEF score in patients undergoing transcatheter aortic valve implantation
por: Ludwig, Sebastian, et al.
Publicado: (2020)

Cardiac arrest in patients hospitalized for COVID-19: a tertiary medical center retrospective cohort study
por: Luo, S, et al.
Publicado: (2021)

TEMPORAL TREND IN MORTALITY FROM COVID-19 ASSOCIATED WITH CARDIOVASCULAR DISEASE
por: Luo, Shengyuan, et al.
Publicado: (2023)

H(2)FPEF score for predicting future heart failure in stable outpatients with cardiovascular risk factors
por: Suzuki, Satoru, et al.
Publicado: (2020)

Predicting Group II pulmonary hypertension: diagnostic accuracy of the H2FPEF and OPTICS scores in Scotland
por: Stubbs, Harrison, et al.
Publicado: (2022)

Identification of Patients with Preclinical Heart Failure with preserved Ejection Fraction Using the H(2)FPEF Score
por: Koepp, Katlyn E., et al.
Publicado: (2022)

Prognostic Impact of Modified H2FPEF Score in Patients Receiving Trans-Catheter Aortic Valve Replacement
por: Akao, Kousuke, et al.
Publicado: (2023)

The relationship between H2FPEF score and contrast induced nephropathy in patients with ST elevation myocardial infarction
por: Ceylan, Ufuk Sadik, et al.
Publicado: (2022)

The ventilatory abnormalities and prognostic values of H(2)FPEF score in dyspnoeic patients with preserved left ventricle systolic function
por: Huang, Wei‐Ming, et al.
Publicado: (2020)

Pregnancy During Cardiology Training: We Need a Policy
por: Oliveros, Estefania, et al.
Publicado: (2019)

The HFA‐PEFF and H(2)FPEF scores largely disagree in classifying patients with suspected heart failure with preserved ejection fraction
por: Sanders‐van Wijk, Sandra, et al.
Publicado: (2020)

Value of the HFA‐PEFF and H(2)FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis
por: Tomasoni, Daniela, et al.
Publicado: (2022)

Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID‐19
por: Luo, Shengyuan, et al.
Publicado: (2022)

Ischemic Stroke in Non-Gender-Related CHA(2)DS(2)-VA Score 0~1 Is Associated With H(2)FPEF Score Among the Patients With Atrial Fibrillation
por: Kim, Min, et al.
Publicado: (2022)

One-Year Change in the H(2)FPEF Score After Catheter Ablation of Atrial Fibrillation in Patients With a Normal Left Ventricular Systolic Function
por: Kim, Min, et al.
Publicado: (2021)

Impact of Modified H(2)FPEF Score on Chronic Limb-Threatening Ischemia in Patients With Lower Extremity Artery Disease Who Underwent Endovascular Therapy
por: Shikama, Taku, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9s75ri6i79hqgrqgrmlk0vftf6